You are here: Industry Insights > ITM

News List

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors B3Cnewswire
December 03, 2021
ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company and Navigo Proteins GmbH, a premier protein engineering company developing optimized scaffold protein-based affinity ligands...
Navigo Proteins GmbH Announces Extension of Partnership with ITM for Targeted Radio Conjugates B3Cnewswire
October 13, 2021
Navigo Proteins, a premier protein engineering company developing optimized scaffold protein-based affinity ligands from its Precision Targeting toolbox today announces the extension of their ongoing partnership with ITM SE...
ITM, DCB sign agreement for Targeted Radionuclide Therapy biospectrumasia
September 03, 2019
The agreement sets out terms concerning the local development, registration and subsequent commercialization by DCB of ITM’s proprietary brand Solucin® for Targeted Radionuclide Therapy (TRT).
ITM, United Imaging to cover Chinese and global cancer imaging markets biospectrumasia
April 04, 2019
Both companies have experience in the field of precision cancer imaging, complementary products as well as similar market objectives
Endocyte and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177 firstwordpharma
July 10, 2018
WEST LAFAYETTE, Ind. & GARCHING, Germany--(BUSINESS WIRE)-- Endocyte, Inc. (Nasdaq:ECYT), and ITM Isotopen Technologien München AG (ITM)